290 related articles for article (PubMed ID: 26791964)
1. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
[TBL] [Abstract][Full Text] [Related]
2. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
[TBL] [Abstract][Full Text] [Related]
3. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
[TBL] [Abstract][Full Text] [Related]
5. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
6. Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Bakhshi S; Pushker N; Sharma A; Kashyap S; Bajaj MS; Singh VK
Br J Ophthalmol; 2020 Jun; 104(6):879-884. PubMed ID: 30940620
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
[TBL] [Abstract][Full Text] [Related]
8. Ocular sebaceous gland carcinoma: an update of the literature.
Cicinelli MV; Kaliki S
Int Ophthalmol; 2019 May; 39(5):1187-1197. PubMed ID: 29696467
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of stress-responsive protein sestrin2 and its correlation with p53 mutational status in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Rangarajan S; Ray N; Vasu K; Singh VK; Phartyal R; Yadav S; Verma A
Br J Ophthalmol; 2018 Jun; 102(6):848-854. PubMed ID: 29478030
[TBL] [Abstract][Full Text] [Related]
10. Integrated Whole-Exome and Transcriptome Sequencing Indicated Dysregulation of Cholesterol Metabolism in Eyelid Sebaceous Gland Carcinoma.
Wang Y; Li J; Hao P; Li J; Han R; Lin J; Li X
Transl Vis Sci Technol; 2023 Feb; 12(2):4. PubMed ID: 36735267
[TBL] [Abstract][Full Text] [Related]
11. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of X-linked inhibitor of apoptosis in eyelid sebaceous gland carcinoma predicts a worse prognosis.
Jayaraj P; Sen S; Dhanaraj PS; Jhajhria R; Singh S; Singh VK
Indian J Ophthalmol; 2017 Nov; 65(11):1109-1113. PubMed ID: 29133634
[TBL] [Abstract][Full Text] [Related]
13. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
Sen S; Bhardwaj M; Jayaraj P; Bakhshi S; Pushker N; Kashyap S; Bajaj MS; Khandpur S
Acta Ophthalmol; 2023 Feb; 101(1):49-56. PubMed ID: 35751173
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of PD-L1 and PD-1 expression in aggressive eyelid sebaceous gland carcinoma and its clinical significance.
Jayaraj P; Sen S
Indian J Ophthalmol; 2019 Dec; 67(12):1983-1987. PubMed ID: 31755433
[TBL] [Abstract][Full Text] [Related]
15. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
[TBL] [Abstract][Full Text] [Related]
16. Programmed death receptor Ligand 1 expression in eyelid sebaceous carcinoma: a consecutive case series of 41 patients.
Xu S; Yu H; Fu G; Fan X; Jia R
Acta Ophthalmol; 2019 May; 97(3):e390-e396. PubMed ID: 29862664
[TBL] [Abstract][Full Text] [Related]
17. Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
Yunoki T; Tabuchi Y; Hayashi A
Anticancer Res; 2017 Apr; 37(4):1931-1934. PubMed ID: 28373462
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of immune checkpoints in the tumour-stromal microenvironment of sebaceous gland carcinoma.
Singh L; Singh MK; Rizvi MA; Pushker N; Bakhshi S; Sen S; Kashyap S
Br J Ophthalmol; 2021 Jan; 105(1):48-56. PubMed ID: 32277010
[TBL] [Abstract][Full Text] [Related]
19. Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids.
Tsai YJ; Wu SY; Huang HY; Ma DH; Wang NK; Hsiao CH; Cheng CY; Yeh LK
BMC Ophthalmol; 2015 Oct; 15():142. PubMed ID: 26503156
[TBL] [Abstract][Full Text] [Related]
20. Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.
Cho KJ; Khang SK; Koh JS; Chung JH; Lee SS
J Korean Med Sci; 2000 Oct; 15(5):545-50. PubMed ID: 11068992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]